To design a new score on risk assessment for orthotopic liver transplantation (OLT) based on both donor and recipient parameters. Background: The balance of waiting list mortality and posttransplant outcome remains a difficult task in the era of the model for end-stage liver disease (MELD). Methods: Using the United Network for Organ Sharing database, a risk analysis was performed in adult recipients of OLT in the United States of America between 2002 and 2010 (n = 37,255). Living donor-, partial-, or combined-, and donation after cardiac death liver transplants were excluded. Next, a risk score was calculated (balance of risk score, BAR score) on the basis of logistic regression factors, and validated using our own OLT database (n = 233). Finally, the new score was compared with other prediction systems including donor risk index, survival outcome following liver transplantation, donor-age combined with MELD, and MELD score alone. Results: Six strongest predictors of posttransplant survival were identified: recipient MELD score, cold ischemia time, recipient age, donor age, previous OLT, and life support dependence prior to transplant. The new balance of risk score stratified recipients best in terms of patient survival in the United Network for Organ Sharing data, as in our European population. Conclusions: The BAR system provides a new, simple and reliable tool to detect unfavorable combinations of donor and recipient factors, and is readily available before decision making of accepting or not an organ for a specific recipient. This score may offer great potential for better justice and utility, as it revealed to be superior to recent developed other prediction scores. (Ann Surg 2011;254:745-753) 
D riven by the need to decrease waiting list mortality, liver graft allocation by disease severity has been introduced in the United States of America in March 2002, followed by Eurotransplant (Germany, Belgium, The Netherlands, Austria, Luxemburg, Croatia, Slovenia), France, Italy, and Switzerland. Accordingly, liver transplant candidates are prioritized in these countries by their highest From model for end-stage liver disease (MELD ) score, because this scoring system was shown to be an accurate predictor of waiting list mortality. 1 However, several transplant centers are critically evaluating, whether a "sickest first" policy would decrease long-term survival after orthotopic liver transplantation (OLT). In this context, a recent European multicentric analysis showed a concerning severe decrease in 3-month and 1-year posttransplant survival with the introduction of liver allocation through MELD. 2 Such results, however, stand in contrast to other centers in Europe 3, 4 and to previous analyses of US data, which have repeatedly shown that recipient MELD score alone was a poor predictor of mortality after OLT. 5, 6 The question raises, therefore, which additional factors are responsible for discrepancies in outcome after OLT, and how to avoid unfortunate risk accumulation in high MELD recipients.
Many attempts have been undertaken to better predict outcome prior to the transplantation procedure. [7] [8] [9] [10] [11] We have tested a number of recently developed score systems in our population, either based on models considering donor (donor risk index, DRI) 7 or recipient factors alone (survival after liver transplantation score), 9 or others, which combine 2 dominant factors in donors and recipients (donor age and recipient MELD, D-MELD), 10 or even an extensive list of donor and recipient parameters (survival outcome following liver transplantation, SOFT). 8 Both strategies have disadvantages, as for example the selection of only one donor and recipient factor (D-MELD) implies no possibility to balance high donor age in high MELD recipients. On the other side, inclusion of numerous covariates (SOFT score) results in less practicability.
The intention of this study was to search for an easily applicable score system, based on the combination of a few independent donor and recipient key factors, with the highest possible accuracy in the prediction of postliver transplant survival.
Statistical Analysis
To establish a most validated regression model, we decided to choose parameters, which are easily available for surgeons in each transplant center worldwide. Our idea was, therefore, to combine only a few donor, graft, and recipient factors in one practical score system on posttransplant patient survival. All factors should be assessable prior to transplant. Furthermore, we opted to prefer metric variables, as this has been shown to result in more robust models. Accordingly, significant variables of current prediction models 7, 8, 10 were selected (4 metric, 2 dichotomous), for example, donor age and cold ischemia, based on the DRI, 7 and MELD score, recipient age, retransplantation, and life support (mechanical support), corresponding to ventilator dependence or bioartificial liver support based on the SOFT score. 8 In an attempt to increase information on graft quality, donor body mass index (BMI) was also included as surrogate marker of steatosis and other metabolic disorders. 24 Factors, which were simultaneously weighted by the MELD score, for example, dialysis before transplant, encephalopathy, ascites, or portal bleeding, were not considered in this analysis.
Multiple imputation 12 was performed for incomplete predictors in the US database such as recipient MELD score pretransplant (4.9% missing), donor age (0.003% missing) and cold ischemia of the graft (11% missing). Fractional polynomials and bootstrapping was applied for testing the functional form of the variables. 13, 14 Multivariable logistic regression (stepwise backward) was performed combining 500 bootstraps [15] [16] [17] [18] and the strongest predictors for 3-month survival after liver transplantation were identified with 75% to 80% repetitions after 500 bootstraps. A shrinkage procedure 19 was used to reduce the risk of over fitting the associations of the predictors with the outcome. In a next step, a point system was developed to enhance clinical applicability according to the Framingham risk score. 20
Validation
The model was calibrated by comparing observed and predicted event rates for groups of patients. A discrimination (c-statistic) analysis differentiated 3-month patient survival after OLT. 21 Internal validation was performed using bootstrapping and k-fold cross validation to estimate the accuracy of the predictive model. 13 The model was validated externally in our own population from January 1, 2003, to October 25, 2010 (n = 233).
Statistical analysis was performed using Stata 10.1.
RESULTS

Are There Differences Between the US and European Study Populations?
Following eligibility criteria, 37,255 cases were selected of the UNOS database ( Figure 1 ) and 233 patients of our database. Median follow-up accumulated to 716 days in the United States, as compared to 865 days in our population. No differences were found between our population and the selected UNOS data in terms of recipient age (median 53 vs 54 years), recipient BMI (24.0 vs Cold ischemia time* (h) 7.0 (5.5-8.5) 7.0 (5.5-8.5) 7.0 (6-9) *Results reported in median and interquartile range.
28.0 kg/m 2 ), donor BMI (median 24.0 vs 25.8 kg/m 2 ), and MELD score at transplant (median 18 vs 18). However, despite the same allocation policy by MELD in both study populations, the median waiting time to transplant was much higher in our country (167 vs 65 days) due to large discrepancies in donation rates (Tables 1 and  2 ). Major differences (own data vs United States) were noted regarding donor age (median 52 vs 43 years), cold ischemia time (median 8.6 vs 7.0 hours), and consecutively in D-MELD (median 825 vs 750), and DRI (median 1.71 vs 1.38) scores. In addition, the percentage of retransplantations and life support at the time of transplant seemed higher in our population (11.6% vs 7.6% and 9.8% vs 4.1%; Tables 1 and 2 ).
Which Are the Key Prediction Factors for Patient Survival After OLT?
Calculations were started in the large US database and tested, in a next step, in our population. From the initially included 7 parameters, 6 revealed as significant predictors, that is, MELD score, cold ischemia time, recipient age, donor age, previous liver transplantation, and life support at the time of transplant (Table 3 ). Donor BMI was not identified as independent predictor. Using the significant regression coefficients, a balance of risk (BAR) score was calculated with a range from 0 to 27 points reflecting an exponential increase in 3-month mortality. The strongest predictor was recipient MELD score (0-14 points), followed by retransplantation (0 or 4 points), recipient age (0-3 points), life support before transplant (0 or 3 points), cold ischemia time (0-2 points), and donor age (0-1 points; Table 3 ).
Internal validation yielded a c-statistic of 0.7. Differences between predicted and observed risks (calibration) were not significant (0.434, Hosmer-Lemeshow test), corresponding to a well-calibrated model. Cross validation (10-fold) confirmed an area under the curve of 0.7.
Is the Newly Developed Risk Score Superior to Other Available Prediction Systems?
In an attempt to compare predictability of outcome, c-statistics of other score systems were assessed in the UNOS database referred to 3-month patient survival. For DRI, MELD, and D-MELD scores the areas under the receiver operator characteristic curves were 0.5, 0.6, and 0.6, respectively ( Figure 2 ). Accordingly, patient survival through 7 years was poorly stratified by DRI and MELD and also by D-MELD clusters ( Figure 2 ). In contrast, SOFT and BAR scores showed a clear decrease in survival per increasing score clusters (0-5, 6-10, 11-15, 16-20, >20; Figure 2 ). Additional analysis showed that cumulative 5-year survival per each single score point followed a linear decline for MELD and SOFT scores in contrast to an exponential decrease for the BAR score above a certain threshold of approximately 18 points (Figure 3 ). To further discriminate BAR and SOFT scores, we grouped patients in terms of cutoff values with similar survival rates, that is, 60% 5-year patient survival was achieved for 15 SOFT points, corresponding to a BAR score of 18 (Figure 3 ). Of note, BAR score grouping at this threshold (≤18 vs >18) splitted patient survival (US data and own population) best as compared to any other score, that is, MELD (≤30 vs >30), D-MELD (≤1600 vs >1600), DRI (≤1.4 vs >1.4), and also SOFT scores (≤15 vs >15; Table 4 and Figure 5 ). Furthermore, BAR ranking was especially useful in high MELD (≥30) recipients in the United States and our population (n = 7451/37,255, 20%, n = 50/233, 21.5%, respectively) to identify those cases with significant worse overall outcome (Table 4; Figure  5 ). Exclusion of BAR more than 18 patients from liver transplant due to expected poor prognosis would refer to 3% of patients in the United States (1117/37,255) and to 7% of cases in our population (16/233). recipient and donor factors, such as intensive care unit care, MELD > 30, dialysis, encephalopathy, ascites, and life support prior to OLT. However, both score systems did not correlate with MELD scores in the UNOS population (DCD and partial grafts excluded), as demonstrated on scatter plots (Figure 4 ; R 2 = 0.002, R 2 = 0.138). In contrast, because of its stepwise increase of score points (0-14) per increasing MELD score (6 to >35; Table 3 ), the BAR score correlated strongly with the MELD score (R 2 = 0.803; Figure 4 ). Despite this fact, a significant amount of patients with high (≥30) MELD scores (6386/7451, 86% in the United States and 34/50, 68% in our population, Table 4 ) remained below or at the threshold of BAR score 18, reflecting a low sum of other risk factors (Table 5; Figure 4) .
In contrast, D-MELD and SOFT and DRI ranked a much higher percentage of MELD ≥ 30 patients or more exceeding cutoffs for D-MELD (>1600), SOFT (>15), or DRI (>1.4 Table 4 ; Figure 4 ).
DISCUSSION
Our search for a new score to optimize utility and justice for allocation of liver grafts has led to a number of new aspects. First, by combining a few major donor and recipient parameters, we developed a simple score system which best stratifies patient survival after OLT, as compared to all recent developed prediction concepts. Second, this score proved to be highly discriminatory in the UNOS database, and also in our own European population. Third, our calculations represent the largest analysis of liver transplant recipients after MELD score implementation.
Two developments have changed the decision-making process in liver transplantation. First, the introduction of the MELD score led to prioritizing of the sickest candidates for OLT. Second, extended criteria donor (ECD) liver grafts have been increasingly used by most to expand the scarce donor pool and to decrease time to transplantation. Because posttransplant patient survival depends on preoperative Table 4 ), remained below or at the threshold of BAR score 18, reflecting a low sum of other risk factors (Table 5 ). In contrast, D-MELD and SOFT and DRI ranked a much higher percentage of MELD ≥ 30 patients exceeding cutoffs (Table 4 ).
medical conditions of both the recipient and donor, transplant surgeons are often faced with the difficult decision whether to accept high-risk donor liver offers for high-risk recipients. However, although waiting list mortality is well understood in relation to increasing MELD score, the mortality risk of different donor/recipient combinations is less well defined. Several authors attempted, therefore, to develop models to predict the likelihood of graft and patient survival after OLT. [7] [8] [9] [10] [11] In one detailed analysis, Feng et al 7 identified 8 donor factors predicting graft failure after transplantation by the DRI, which combines donor age, donor height, DCD donors, split liver donors, black race, donor cause of death from cerebrovascular accident, regional sharing, and cold ischemia time). However, the lack of additional recipient factors results in poor predictive value for DRI in terms of patient survival after OLT. In addition, 2 strong parameters, DCD and partial liver graft transplantation contribute to only a few percentages (<8% in the United States of America) of the whole population, and are exceptional in many other areas such as in Switzerland (<1%). Thus, the DRI seems less suitable to stratify posttransplant patient survival (Figure 2 ). Additional models have therefore been calculated to identify better risk combinations as, for example, the D-MELD, being the product of 2 metric variables (donor age and calculated preoperative MELD). D-MELD scoring can quickly and accurately estimate a risk for various donor/recipient combinations at the bedside. However, although the strength of D-MELD is its simplicity, this seems also as limitation. Accordingly, the proposal of the authors of D-MELD to eliminate donor/recipient matches with D-MELD > 1600 results in the need to consider donors with an age below 54 for every MELD > 30 recipients. Such policy would be unrealistic in many European countries, because donor age is significantly higher in Europe (median 53, mean 48 year) than in the United States (median 43, mean 39 years). 7, 22 Our hypothesis was, therefore, to more precisely identify high-risk transplant donor/recipient matches before transplant by a combination of a few relevant donor and recipient key parameters.
Although the principle of inclusion of several donor, graft, and recipient factors in one prediction model has been previously formulated in the SOFT model 8 and others, 5,11 the novel approach presented here is the reduction to a few variables with less probability of interaction and with high correlation to the MELD score. For example, the SOFT score considers 18 different covariates with the strongest predictors being previous transplantation, life support or intensive care unit stay prior to transplantation. Other variables clearly overlap with these factors as, for example, dialysis before transplantation, encephalopathy, ascites, and the need for ventilation. With increasing MELD scores the SOFT model, as the D-MELD, and also previous score models 5, 11 and the DRI are less useful to decide whether to transplant or not a sick candidate. The reason behind that lays in the fact that both, candidates with low, or candidates with high MELD scores can, in principle, achieve a wide range of score values in SOFT, D-MELD, and DRI score systems (Figure 4 ). This variation of points in every MELD stage seems unsuitable for ranking transplant candidates and making informed decision, because grouping of SOFT score, or DRI at any level results in homogeneous distribution of morbidity.
In contrast, the new BAR score system discriminated best in terms of survival and overall mortality below and above cutoff of 18 (Table 4 ; Figure 5 ). Importantly most patients with MELD ≥ 30 were ranked below this threshold. For example, candidates for liver retransplantation with MELD score between 25 and 35 and the need for life support reach a BAR score at 18 or below, if recipient age is 60 years or less, and cold ischemia is kept below or at a maximum of 6 hours, and donor age is less or equal than 40 years ( Table 5 ). In candidates with higher MELD scores (>35), only one of the risk factors retransplantation or life support can be balanced by either young recipient and donor age or cold ischemia ( Table 5 ).
The shortcoming of BAR is the lack of consideration of additional graft factors like hepatic steatosis. 23 As data are worldwide scarce in terms of liver biopsies, we could not adjust our regression analysis to graft histology. Despite correlation of BMI and steatosis in a recent study, 24 we were also not able to demonstrate donor BMI as independent predictor.
Another point to discuss is the question how to determine bestcutoffs for the decision to transplant or not. A threshold of BAR at 18 was postulated due to the observation that survival starts to deteriorate at this point (Figure 3 ). Whether higher BAR score recipients would benefit from improved preservation strategies or donor and recipient treatment remains to be tested. 25 Additional important factors in extreme sick candidates, which help in the decision process, as the amount of pressors needed, or the percentage of oxygenation, could not be addressed by our score due to the absence of most data. However, because survival difference between groups below and above cutoff is highest despite exclusion of the least patients from potential benefit by liver transplantation (Table 4 ), we suggest the new BAR system as currently best model for defining a threshold of acceptable outcomes after liver transplantation. 26, 27 A significant advantage of BAR is the fact, that it derives from objective factors, readily available at the time of an organ offer, except for the cold ischemia, which can, however, be estimated in most cases. Compared with other scores, all variables are worldwide documented in a standard way.
We developed this score from the US data and applied it in our small population. In face of the ongoing discussion on the MELD policy in terms of justice and utility, [28] [29] [30] there is an urgent need for further validation of all available score systems in Europe. BAR has, from our view, the greatest potential to be helpful in deciding at which point a high-risk liver transplant candidate should not be transplanted.
In summary, BAR score seems highly suitable to identify in a fast, easy and reproducible manner, poor donor/recipient matches, which may guide for allocation of a specific organ for a specific recipient. Thus, informed decision can be made to optimize the survival rate/resource utilization ratio and maximize the benefit from the limited resource of donor livers. On line calculation of BAR score provided by barscore.org/.
DISCUSSANTS D. Jaeck (Strasbourg, France):
You addressed a crucial issue, which is how to better select the patients who should receive a transplant in the group of patients with a MELD score of more than 30. You claim that the proposed new BAR system can detect an unfavorable combination of donor and recipient factors.
You did not perform a univariate analysis on all the important risk factors like the study concerning the SOFT score. Could there be a potentially important risk factor associated with patient survival that was overlooked? Second, the comparison of survival between the Zurich and the United States series in patients with a BAR score more than 18 shows that the US population has a considerably better prognosis than the Zurich population. Indeed the median survival was 52 months in the United States versus 25 months in your group. The P value was not given, but how do you explain such a difference?
Finally this new score that you proposed should be tested on a wider scale and should be compared not only with the US groups but also within the European groups.
Response From P. Dutkowski:
Your first question addresses the methodology of our logistic regression analysis. Generally, there is no rule, how to best select variables for inclusion in regression analysis. In principal, factors could be identified by univariate analysis, as you suggested, or by their clinical impact, as we did in this study. Both strategies have been applied in the past, and both methods have advantages and disadvantages. In this study, we decided to consider the most relevant factors known according to previous risk models.
The second question addresses the difference in outcome in patients exceeding BAR 18 between the United States and our population. First, the numbers of cases are far different, only 16 of our patients were in that range compared with more than 1000 in the UNOS population, which might well contribute to differences in mean survival. Furthermore, it could be that graft quality is even more different than we believe, because additional factors, as for example graft steatosis, were not included in our model. Importantly, however, survival in cases below or at BAR 18 was similar in both populations (US and Zurich).
DISCUSSANTS K. Boudjema (Rennes, France):
You showed us how important the score was in predicting the survival of patients with a score of more than 30, but you calculated survival starting with the day of transplantation. I think this is an erroneous way to calculate survival in liver transplantation. You should have started calculation at the time you put the patient on the waiting list, taking into account those patients who drop out during the waiting phase. Can you comment on this?
Response From P. Dutkowski:
You address the survival benefit analysis, which is a method that considers mortality both before and after transplantation. In this study, we intended to search for key factors of outcome after transplantation, not to replace current allocation models, because several parameters are not known at the time of listing, but are given or to be estimated at the time of graft allocation. In addition, a MELD 40 patient might benefit already from liver transplantation if he survives for 3 months after transplantation, because without transplantation, his prognosis is probably only 2 weeks. However, such outcome might be questionable to justify liver transplantation despite the benefits; therefore, we were interested in key factors for long-term survival. In the next step, posttransplant outcome should be compared to waiting list mortality.
DISCUSSANTS M. Krawcyz (Warsaw, Poland):
In every case, we must remember that we have a unique recipient. This means that the score is only one factor-albeit a key one-for our decision on which liver for which patient. In a clinical context we analyze the size of donor's liver, the weight of the recipient, the distance from the recipient's location, and many other variables. All these data are important for our decision, and not only the information based on the score system. Of course as you argued, a better score helps us to allocate the liver in a more transparent and more objective way. That said, in every case it is necessary to remember that we treat the patient, not their score.
Response From P. Dutkowski:
We agree that the decision to transplant, or not, should be not only made by a score, because the threshold depends on what every transplant center is willing to accept as risk. For example, you can put the threshold at BAR score 16 or at BAR score 20, but the risk of mortality after transplantation clearly increases with increasing score. We decided to put the threshold at BAR score 18 because mortality increases exponentially above this level.
